Programmed Cell Death Protein 1 (PD-1) Molecule in Coronavirus Disease 2019 (COVID-19)?

Document Type : Letter to Editor

Authors

• Esmaeil Mortaz ^{1, 2}
• Hamidreza Jamaati ³
• Mohammad Varahram ⁴
• Neda K. Dezfuli ^{5, 6}
• Ian M. Adocok ^{7, 8}

¹ Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran,

² Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran,

³ Chronic Respiratory Diseases Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran

⁴ Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

⁵ Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

⁶ Department of Immunology and Laboratory Sciences, School of Allied Medical sciences, Dezful University of Medical Sciences, Dezful, Iran

⁷ National Heart and Lung Institute, Imperial College London, London, United Kingdom

⁸ Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia